ORLANDO, Viviana
 Distribuzione geografica
Continente #
NA - Nord America 608
EU - Europa 412
AS - Asia 94
AF - Africa 15
SA - Sud America 2
Totale 1.131
Nazione #
US - Stati Uniti d'America 601
IT - Italia 293
IN - India 41
SE - Svezia 41
CN - Cina 27
FI - Finlandia 20
TG - Togo 13
DE - Germania 12
BG - Bulgaria 10
SG - Singapore 10
GB - Regno Unito 9
UA - Ucraina 9
FR - Francia 8
CA - Canada 7
IR - Iran 5
TR - Turchia 5
BE - Belgio 4
RO - Romania 3
PK - Pakistan 2
AR - Argentina 1
BH - Bahrain 1
BR - Brasile 1
CI - Costa d'Avorio 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
KZ - Kazakistan 1
MY - Malesia 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 1.131
Città #
Rome 188
Fairfield 104
Ashburn 65
Woodbridge 40
Seattle 38
Chandler 32
Cambridge 30
Wilmington 29
Ann Arbor 27
Houston 25
Princeton 19
Beijing 15
Lomé 13
Fasano 12
Plano 12
Millbury 11
Helsinki 10
San Paolo di Civitate 10
Sofia 10
Dearborn 8
Lawrence 8
New York 8
San Diego 7
Boston 6
Andover 5
Fremont 5
Washington 5
Brussels 4
Istanbul 4
Norwalk 4
Salerno 4
Avellino 3
Des Moines 3
Florence 3
Hefei 3
Jacksonville 3
Oxford 3
Philadelphia 3
Phoenix 3
Pontelandolfo 3
Pune 3
Redwood City 3
Southend 3
Aprilia 2
Bari 2
Cassano delle Murge 2
Crévic 2
Dijon 2
Kunming 2
Ottawa 2
Padula 2
Tappahannock 2
Tianjin 2
Toronto 2
Waltham 2
Abidjan 1
Absecon 1
Alatri 1
Albuquerque 1
Anaheim 1
Ankara 1
Berlin 1
Boardman 1
Budapest 1
Ceccano 1
Changchun 1
Chicago 1
Cinisello Balsamo 1
Dublin 1
Fairview 1
Falls Church 1
Federal 1
Ferndale 1
Galdo 1
Gloucester 1
Holon 1
Liscate 1
London 1
Los Angeles 1
Muizenberg 1
Mumbai 1
Nanjing 1
Napoli 1
New Delhi 1
Oakville 1
Oristano 1
Palermo 1
Parma 1
Pescara 1
Pescorocchiano 1
Prime 1
Redmond 1
Ridder 1
San Francisco 1
San Genesio Ed Uniti 1
San Mateo 1
Santa Rosa 1
Selargius 1
Signa 1
Singapore 1
Totale 863
Nome #
Drug design and synthesis of first in class PDZ1 targeting NHERF1 inhibitors as anticancer agents 160
Anticancer activity of (S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((pyridin-4-ylmethyl)amino)propan-2-yl)-1H-indole-2-carboxamide (RS4690), a new dishevelled 1 inhibitor 98
Structure-activity relationship studies and in vitro and in vivo anticancer activity of novel 3-aroyl-1,4-diarylpyrroles against solid tumors and hematological malignancies 91
Dysregulated homeostasis of acetylcholine levels in immune cells of RR-multiple sclerosis patients 82
Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: Implication in peripheral inflammation 78
Discovery of pyrrole derivatives for the treatment of glioblastoma and chronic myeloid leukemia 77
Modulating intracellular acidification by regulating the incubation time of proton caged compounds 60
null 60
Toward an objective evaluation of cell transfection performance 60
null 55
Transfection of mouse neuroblastoma N18TG2 cells with Metafectene Pro reagent 52
Surface functionalized multicomponent envelope type nanosystems for improved gene delivery 49
Direct HPLC enantioseparation of chiral aptazepine derivatives on coated and bonded polysaccharide-based chiral stationery phases. 49
Acetylcholine induces changes in protein folding regimen and cytoskeleton organization 45
Design, synthesis and biological evaluation of PDZ1 targeting NHERF1 inhibitors as anticancer agents 43
Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as an Anticancer Agent 43
null 32
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells 22
Top-down n-doped carbon quantum dots for multiple purposes: Heavy metal detection and intracellular fluorescence 21
Exogenous control over intracellular acidification: Enhancement via proton caged compounds coupled to gold nanoparticles 10
Exogenous control over intracellular acidification: Enhancement via proton caged compounds coupled to gold nanoparticles and an alternative pathway with DMSO 7
Inflammatory cytokines and cholinergic system dis-function in multiple sclerosis patients. 5
Totale 1.199
Categoria #
all - tutte 3.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.116


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201996 0 0 0 0 0 0 0 0 0 21 42 33
2019/2020255 29 10 7 9 20 41 32 26 26 37 8 10
2020/2021102 13 8 7 6 1 4 4 10 10 11 14 14
2021/2022248 14 3 26 10 20 8 9 18 35 17 36 52
2022/2023205 40 42 8 9 20 16 5 16 34 7 7 1
2023/2024177 18 22 15 10 15 29 18 23 12 15 0 0
Totale 1.199